Omalizumab Subcutaneous and Pedia-Lax Chewable
Determining the interaction of Omalizumab Subcutaneous and Pedia-Lax Chewable and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: omalizumab
Brand name: Xolair, Xolair Prefilled Syringe
Synonyms: Omalizumab
Generic Name: magnesium hydroxide
Brand name: Ex-Lax Milk of Magnesia, Milk of Magnesia, Pedia-Lax Chewable, Phillips Milk of Magnesia, Dulcolax Milk of Magnesia, Concentrated Phillips Milk of Magnesia
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Omalizumab Subcutaneous-Pedia-Lax Liquid rectal
- Omalizumab Subcutaneous-Pediacare
- Omalizumab Subcutaneous-PediaCare Children’s Multi-Symptom
- Omalizumab Subcutaneous-PediaCare Cold/Allergy
- Omalizumab Subcutaneous-Pediacare Decongestant Infants
- Omalizumab Subcutaneous-Pediacare Long-Acting Cough
- Pedia-Lax Chewable-Ombitasvir, Paritaprevir, and Ritonavir
- Pedia-Lax Chewable-Ombitasvir, paritaprevir, ritonavir and dasabuvir
- Pedia-Lax Chewable-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Extended-Release Tablets
- Pedia-Lax Chewable-Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir Tablets
- Pedia-Lax Chewable-Omeclamox-Pak
- Pedia-Lax Chewable-Omega-3 Fatty Acid Capsules